Macerich (MAC) stock outlook for 2026: how the Path Forward deleveraging plan and improving occupancy set up a re-rating case, why leverage still caps it, how to read FFO and REIT dividends, and what to watch each quarter.
GFL Environmental stock outlook for 2026: how North America's fourth-largest solid waste company is cutting debt and lifting margins after selling its Environmental Services arm, plus landfill moat, M&A risk and valuation versus WM and Republic.
UNFI (United Natural Foods) stock outlook for 2026: how the largest US natural and organic grocery distributor makes money, the Whole Foods contract through 2032, debt paydown and free cash flow, margin risks, peers, and tax and FX scenarios.
PRGO (Perrigo) 2026 stock outlook: how the largest US store-brand OTC and infant formula maker earns its margins, why formula supply normalization and non-core divestitures drive the turnaround, and where recalls, debt and price competition can derail it.
CLMT (Calumet) stock outlook for 2026: specialty-products refining moat, Montana Renewables SAF ramp, deleveraging progress, the C-corp conversion, crack spread sensitivity, and tax and FX scenarios for US and international investors.
Kosmos Energy (KOS) 2026 stock analysis: deepwater production in Ghana, Equatorial Guinea and the Gulf of America, GTA LNG, oil-price beta, leverage and deleveraging, E&P peer comparison, and what US investors should watch each quarter.
Prestige Consumer Healthcare (PBH) 2026 stock outlook: niche No. 1 and No. 2 OTC brands like Breathe Right, Dramamine and Summer's Eve, an outsourced high-margin model, free cash flow, deleveraging, and the risks of acquisition dependence and private-label pressure.
Columbus McKinnon (CMCO) stock outlook 2026: a qualitative deep dive into the ~$2.7B Kito Crosby acquisition, the roughly $70M synergy target, the post-deal deleveraging story, aftermarket moat, integration risk, and industrial-cycle exposure for US investors.
Primo Brands (PRMB) stock outlook for 2026: a qualitative look at the Poland Spring, Arrowhead, Deer Park and Pure Life brand portfolio, the Water Direct home and office delivery subscription model, the 2024 Primo Water-BlueTriton merger, deleveraging progress and key risks like PFAS litigation and plastics regulation.
DAN (Dana Incorporated) stock outlook 2026: what the Off-Highway divestiture to Allison, completed January 1, 2026, means for driveline and e-Propulsion focus, deleveraging plans, commercial vehicle cycle risk, and margin execution.
A frank 2026 analysis of Avantor (AVTR). We break down the spec-in consumables moat in bioprocessing and ultra-high-purity chemicals, the Lab Solutions distribution versus Bioscience Production split, post-destocking demand recovery, the leverage that shapes the story, cost-out execution, and how AVTR stacks up against Thermo, Danaher, Sartorius, and Repligen.
Regal Rexnord (RRX) 2026 stock analysis: the Rexnord PMC and Altra integration, debt paydown, cost and revenue synergies, growing powertrain aftermarket, automation demand, and short-cycle industrial risk explained in depth.
Celanese (CE) 2026 stock outlook. A deep qualitative look at the cost-advantaged Acetyl Chain, Engineered Materials, the debt taken on for DuPont's M and M deal, the dividend cut, asset sales, and what an auto and industrial recovery would mean.